November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
September 20th 2024
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 6, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 5, 2021
Janssen RSV Vaccine for Older Adults Drives Robust Cellular Immune, Humoral Response
Janssen's investigational vaccine showed efficacy of up to 80% in preventing RSV-mediated lower respiratory tract infections in older adults.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 4, 2021
The number of US confirmed deaths has surpassed 702 000. Plus more data on the Delta variant, cases, mortalities, and vaccination in our daily update.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 1, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 30, 2021
Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 29, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 28, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 27, 2021
COVID-19 Boosters: Hope or Hype?
Infectious disease expert and NIH-funded researcher Rodger MacArthur, MD, has questions about the evidence on which the Pfizer booster shot recommendations are based.
Study: Safety Data on HPV Vaccine Improving, but More Parents Still Concerned
A new analysis showed a near 78% increase in citing safety concerns among parents with HPV vaccine hesitancy, contrary to no observed changes in serious adverse event reporting.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 24, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 23, 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine Booster for Select Groups
The Pfizer-BioNTech booster shot is authorized for use in persons aged ≥65 years, at high risk of severe disease, and who have frequent exposure to the virus increasing risk for severe infection.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 22, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 21, 2021
J&J Preprint Data Show Real-world Durability, Promise for Booster Shot Against COVID-19
Strong evidence from a large, real-world evidence study, and preliminary data from a phase 3 booster-dose trial may support J&J's next steps toward FDA authorization of a COVID-19 booster.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 20, 2021
CDC: Moderna Vaccine Shows Highest Efficacy Against Hospitalizations in Healthy Adults
In a new analysis of adults without immunocompromising conditions, vaccine effectiveness against hospitalization was higher for Moderna than Pfizer and Johnson & Johnson.
Pfizer-BioNTech Report COVID-19 Vaccine is Safe, Effective in Children Aged 5 to 11 Years
Pfizer/BioNTech report "robust" antibody response to COVID-19 vaccine in children aged 5 to 11 years with safety profile comparable to that seen in persons aged 16 to 25 years.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 17, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 16, 2021
COVID-19 Hospitalizations for Unvaccinated Cost US Billions
Avoidable COVID-19 hospitalizations for unvaccinated persons in the US have cost an estimated $5 billion since June, according to a new study.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 15, 2021
10 States with the Highest COVID-19 Vaccination Rates, 5 with the Lowest
According to the CDC, Vermont right now has the highest and Wyoming the lowest percentage of its state's population fully vaccinated against COVID-19.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 13, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 10, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 9, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 7, 2021